{"id":"https://openalex.org/W1997960768","doi":"https://doi.org/10.1158/1538-7445.am2014-ct238","title":"Abstract CT238: Phase III randomized, placebo controlled trial of COX-2 inhibition in addition to standard chemotherapy for advanced non-small cell lung cancer (NSCLC):CALGB 30801 (Alliance)","display_name":"Abstract CT238: Phase III randomized, placebo controlled trial of COX-2 inhibition in addition to standard chemotherapy for advanced non-small cell lung cancer (NSCLC):CALGB 30801 (Alliance)","publication_year":2014,"publication_date":"2014-10-01","ids":{"openalex":"https://openalex.org/W1997960768","doi":"https://doi.org/10.1158/1538-7445.am2014-ct238","mag":"1997960768"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2014-ct238","doi":"https://doi.org/10.1158/1538-7445.am2014-ct238","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2014-ct238","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5063441489","display_name":"Martin Joseph Edelman","orcid":"https://orcid.org/0000-0002-3752-0726","observed_orcids":["https://orcid.org/0000-0002-3752-0726"]},"institutions":[{"id":"https://openalex.org/I169521973","display_name":"University of New Mexico","ror":"https://ror.org/05fs6jp91","country_code":"US","type":"education","lineage":["https://openalex.org/I169521973"]},{"id":"https://openalex.org/I4210141130","display_name":"New Mexico Cancer Center","ror":"https://ror.org/03emyr182","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210141130"]},{"id":"https://openalex.org/I4390039284","display_name":"UNM Comprehensive Cancer Center","ror":"https://ror.org/05kx2e072","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I169521973","https://openalex.org/I4390039284"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Martin J. Edelman","raw_affiliation_strings":["1University of New Mexico Cancer Center, Albuquerque, NM;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of New Mexico Cancer Center, Albuquerque, NM;","institution_ids":["https://openalex.org/I169521973","https://openalex.org/I4210141130","https://openalex.org/I4390039284"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100363457","display_name":"Xiaofei Wang","orcid":"https://orcid.org/0000-0002-1266-5670","observed_orcids":["https://orcid.org/0000-0002-1266-5670"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xiaofei Wang","raw_affiliation_strings":["2Duke University, Durham, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Duke University, Durham, NC;","institution_ids":["https://openalex.org/I170897317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110096364","display_name":"Lydia C. Hodgson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lydia Hodgson","raw_affiliation_strings":["2Duke University, Durham, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Duke University, Durham, NC;","institution_ids":["https://openalex.org/I170897317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108628636","display_name":"Richard T. Cheney","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard T. Cheney","raw_affiliation_strings":["3Roswell Park Cancer Institute, Buffalo, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Roswell Park Cancer Institute, Buffalo, NY;","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062111389","display_name":"Maria Quintos Baggstrom","orcid":"https://orcid.org/0000-0002-8918-3565","observed_orcids":["https://orcid.org/0000-0002-8918-3565"]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maria Baggstrom","raw_affiliation_strings":["4Washington University, St. Louis, MO;","#N#4Washington University, St. Louis, MO#N#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Washington University, St. Louis, MO;","institution_ids":["https://openalex.org/I204465549"]},{"raw_affiliation_string":"#N#4Washington University, St. Louis, MO#N#","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050549773","display_name":"Thomas Sachdev","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210136917","display_name":"Illinois CancerCare","ror":"https://ror.org/03vfgta75","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210136917"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas Sachdev","raw_affiliation_strings":["5Illinois Cancer Care, Peoria, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Illinois Cancer Care, Peoria, IL;","institution_ids":["https://openalex.org/I4210136917"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030127760","display_name":"Ajeet Gajra","orcid":"https://orcid.org/0000-0002-5929-0466","observed_orcids":["https://orcid.org/0000-0002-5929-0466"]},"institutions":[{"id":"https://openalex.org/I20388574","display_name":"SUNY Upstate Medical University","ror":"https://ror.org/040kfrw16","country_code":"US","type":"education","lineage":["https://openalex.org/I20388574"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ajeet Gajra","raw_affiliation_strings":["6Upstate Medical University, Syracuse, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Upstate Medical University, Syracuse, NY;","institution_ids":["https://openalex.org/I20388574"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090253314","display_name":"Erin Marie Bertino","orcid":"https://orcid.org/0000-0003-3174-0928","observed_orcids":["https://orcid.org/0000-0003-3174-0928"]},"institutions":[{"id":"https://openalex.org/I2802841970","display_name":"The Ohio State University Wexner Medical Center","ror":"https://ror.org/00c01js51","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2802841970"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Erin Bertino","raw_affiliation_strings":["7Ohio State University Medical Center, Columbus, OH;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Ohio State University Medical Center, Columbus, OH;","institution_ids":["https://openalex.org/I2802841970"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051283101","display_name":"Karen L. Reckamp","orcid":"https://orcid.org/0000-0002-9213-0325","observed_orcids":["https://orcid.org/0000-0002-9213-0325"]},"institutions":[{"id":"https://openalex.org/I1301076528","display_name":"City Of Hope National Medical Center","ror":"https://ror.org/00w6g5w60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karen Reckamp","raw_affiliation_strings":["8City of Hope National Medical Center, Duarte, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"8City of Hope National Medical Center, Duarte, CA;","institution_ids":["https://openalex.org/I1301076528"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038755935","display_name":"Julian R. Molina","orcid":"https://orcid.org/0000-0002-9962-4635","observed_orcids":["https://orcid.org/0000-0002-9962-4635"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Julian Molina","raw_affiliation_strings":["9Mayo Clinic, Rochester, MN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"9Mayo Clinic, Rochester, MN;","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050185260","display_name":"Joan H. Schiller","orcid":"https://orcid.org/0000-0003-0990-1211","observed_orcids":["https://orcid.org/0000-0003-0990-1211"]},"institutions":[{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joan Schiller","raw_affiliation_strings":["10University of Texas Southwestern, Dallas, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"10University of Texas Southwestern, Dallas, TX;","institution_ids":["https://openalex.org/I867280407"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003792633","display_name":"Kisha Mitchell-Richards","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kisha Mitchell-Richards","raw_affiliation_strings":["11Yale University, New Haven, CT;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"11Yale University, New Haven, CT;","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109990299","display_name":"Paula N. Friedman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paula Friedman","raw_affiliation_strings":["12University of Chicago, Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"12University of Chicago, Chicago, IL;","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112278079","display_name":"Jon Ritter","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I130238516","display_name":"University of Minnesota","ror":"https://ror.org/017zqws13","country_code":"US","type":"education","lineage":["https://openalex.org/I130238516"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jon Ritter","raw_affiliation_strings":["13University of Minnesota, Minneapolis, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"13University of Minnesota, Minneapolis, MN","institution_ids":["https://openalex.org/I130238516"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5063904421","display_name":"Everett E. Vokes","orcid":"https://orcid.org/0000-0002-8645-8068","observed_orcids":["https://orcid.org/0000-0002-8645-8068"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Everett Vokes","raw_affiliation_strings":["12University of Chicago, Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"12University of Chicago, Chicago, IL;","institution_ids":["https://openalex.org/I40347166"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":15,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"74","issue":"19_Supplement","first_page":"CT238","last_page":"CT238"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.6567000150680542,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.6567000150680542,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.19380000233650208,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.11379999667406082,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cox-2-inhibition","display_name":"COX-2 inhibition","score":0.902999997138977},{"id":"https://openalex.org/keywords/celecoxib","display_name":"celecoxib","score":0.9729999899864197},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9449999928474426},{"id":"https://openalex.org/keywords/advanced-non-small-cell-lung-cancer","display_name":"advanced non-small cell lung cancer","score":0.875},{"id":"https://openalex.org/keywords/cox-2-expression","display_name":"COX-2 expression","score":0.8090000152587891},{"id":"https://openalex.org/keywords/immunohistochemical-markers","display_name":"immunohistochemical markers","score":0.7409999966621399},{"id":"https://openalex.org/keywords/chemotherapy-toxicity","display_name":"chemotherapy toxicity","score":0.5569999814033508},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.6980000138282776},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9490000009536743},{"id":"https://openalex.org/keywords/carboplatin","display_name":"carboplatin","score":0.7260000109672546},{"id":"https://openalex.org/keywords/pemetrexed","display_name":"pemetrexed","score":0.9929999709129333},{"id":"https://openalex.org/keywords/gemcitabine","display_name":"gemcitabine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/medical-futility","display_name":"futility","score":0.39500001072883606},{"id":"https://openalex.org/keywords/cardiotoxicity","display_name":"cardiotoxicity","score":0.7540000081062317}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8500422239303589},{"id":"https://openalex.org/C2777240266","wikidata":"https://www.wikidata.org/wiki/Q415220","display_name":"Pemetrexed","level":4,"score":0.7527974843978882},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6637223958969116},{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.6563948392868042},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5466738939285278},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.5390443801879883},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.5186559557914734},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.5164670944213867},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.42377984523773193},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.4173364043235779},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3475509583950043},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.23444393277168274},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.1696450114250183},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.06506615877151489}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2014-ct238","doi":"https://doi.org/10.1158/1538-7445.am2014-ct238","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2014-ct238","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2613962944","https://openalex.org/W2553267956","https://openalex.org/W2607235967","https://openalex.org/W2329080604","https://openalex.org/W2120462386","https://openalex.org/W2023474794","https://openalex.org/W1970456088","https://openalex.org/W2008778808","https://openalex.org/W2224011230","https://openalex.org/W3148419375"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Overexpression":[2],"of":[3,19,164,178,286,358,378,383],"COX-2":[4,22,47,81,86,158,211,215,237,245,249,262,265,291,359],"has":[5],"been":[6],"associated":[7,272],"with":[8,43,64,68,85,118,130,157,161,273],"worse":[9],"outcome":[10,33],"in":[11,25,29,41,153,155,213,350,361],"NSCLC.":[12],"In":[13],"C30203,":[14],"we":[15],"found":[16],"that":[17,58],"administration":[18],"the":[20,172,179,191,201,214,379,384],"selective":[21,261],"inhibitor":[23],"celecoxib":[24,136],"addition":[26,362],"to":[27,45,55,135,150,254,290,363],"chemotherapy":[28,234,274,365],"advanced":[30,367],"NSCLC":[31,65],"improved":[32],"(progression":[34],"free":[35],"and":[36,61,76,94,288],"overall":[37],"survival,":[38],"PFS,":[39],"OS)":[40],"pts":[42,117,129,182,256],"moderate":[44],"high":[46],"expression":[48,87,238,250],"by":[49,82,103,171,251],"immunohistochemistry":[50],"(IHC).":[51],"C30801":[52],"was":[53,101,134,149,169,205,225],"designed":[54],"prospectively":[56],"confirm":[57],"finding.":[59],"Patients":[60],"Methods:":[62],"Pts":[63,84],"(stage":[66],"IIIb":[67],"pleural":[69],"effusion,":[70],"IV":[71],"6th":[72],"ed)":[73],"were":[74,98,183,196],"pre-registered":[75],"biopsy":[77],"specimens":[78],"analyzed":[79],"for":[80,116,128,174,210,227,244,347,366,387],"IHC.":[83],">":[88,298,305],"or":[89,142,275,299,306],"=":[90,107,220,300,307],"2,":[91],"PS":[92],"0-2":[93],"normal":[95],"organ":[96],"function":[97],"eligible.":[99],"Chemotherapy":[100],"determined":[102],"histology:":[104],"carboplatin":[105],"(AUC":[106],"6),":[108],"pemetrexed":[109],"(500":[110],"mg/m2)":[111,125],"d":[112,126],"1,":[113],"q21":[114],"days":[115],"non-squamous":[119],"NSCLC;":[120],"carboplatin(AUC=5.5)":[121],"d1,":[122],"gemcitabine":[123],"(1000":[124],"1,8":[127],"squamous":[131],"histology.":[132],"Randomization":[133],"(400":[137],"mg":[138],"bid)":[139],"(Arm":[140,144],"A)":[141],"placebo":[143,355],"B).":[145],"The":[146,167,185],"primary":[147],"endpoint":[148],"demonstrate":[151,241],"improvement":[152],"PFS":[154],"patients":[156],"index":[159],">=4":[160],"hazard":[162],"ratio":[163],"0.645.":[165],"Results:":[166],"study":[168],"halted":[170],"DSMB":[173],"futility":[175],"after":[176],"312":[177],"planned":[180],"322":[181],"randomized.":[184],"current":[186],"analysis":[187],"is":[188],"based":[189],"upon":[190],"first":[192],"300":[193],"pts.":[194],"There":[195,204],"no":[197],"significant":[198],"differences":[199],"between":[200],"groups":[202],"(Table).":[203],"a":[206],"possible":[207,284],"harmful":[208],"effect":[209],"inhibition":[212,266,360],"2-3":[216,296,303],"subset":[217],"(OS":[218],"HR":[219],"1.75,":[221],"p":[222],"=.0977).":[223],"Toxicity":[224],"similar":[226],"both":[228],"arms.":[229],"Subset":[230],"analyses":[231],"evaluating":[232],"histology,":[233],"regimen,":[235],"incremental":[236],"did":[239,267],"not":[240,268],"any":[242],"advantage":[243],"inhibition.":[246,263,292],"Conclusions:":[247],"1.":[248],"IHC":[252],"failed":[253],"select":[255],"who":[257],"could":[258],"benefit":[259],"from":[260],"2.":[264],"significantly":[269],"increase":[270,276],"toxicity":[271,287],"cardiovascular":[277],"morbidity.":[278],"3.":[279],"We":[280],"will":[281],"evaluate":[282],"other":[283],"determinants":[285],"response":[289],"OutcomeArm":[293],"AArm":[294],"BCOX-2":[295],"(n=37)COX-2":[297],"4":[301,308],"(n=111)COX-2":[302],"(n=46)COX-2":[304],"(n=106)PFS":[309],"(months)4.404.934.606.11OS":[310],"(months)9.0310.5814.8512.68":[311],"Citation":[312],"Format:":[313],"Martin":[314],"J.":[315],"Edelman,":[316],"Xiaofei":[317],"Wang,":[318],"Lydia":[319],"Hodgson,":[320],"Richard":[321],"T.":[322],"Cheney,":[323],"Maria":[324],"Baggstrom,":[325],"Thomas":[326],"Sachdev,":[327],"Ajeet":[328],"Gajra,":[329],"Erin":[330],"Bertino,":[331],"Karen":[332],"Reckamp,":[333],"Julian":[334],"Molina,":[335],"Joan":[336],"Schiller,":[337],"Kisha":[338],"Mitchell-Richards,":[339],"Paula":[340],"Friedman,":[341],"Jon":[342],"Ritter,":[343],"Everett":[344],"Vokes,":[345],"Alliance":[346],"Clinical":[348],"Trials":[349],"Oncology.":[351],"Phase":[352],"III":[353],"randomized,":[354],"controlled":[356],"trial":[357],"standard":[364],"non-small":[368],"cell":[369],"lung":[370],"cancer":[371],"(NSCLC):CALGB":[372],"30801":[373],"(Alliance).":[374],"[abstract].":[375],"In:":[376],"Proceedings":[377],"105th":[380],"Annual":[381],"Meeting":[382],"American":[385],"Association":[386],"Cancer":[388,399],"Research;":[389],"2014":[390],"Apr":[391],"5-9;":[392],"San":[393],"Diego,":[394],"CA.":[395],"Philadelphia":[396],"(PA):":[397],"AACR;":[398],"Res":[400],"2014;74(19":[401],"Suppl):Abstract":[402],"nr":[403],"CT238.":[404],"doi:10.1158/1538-7445.AM2014-CT238":[405]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}